4.4 Article

SNOT-22 quality of life domains differentially predict treatment modality selection in chronic rhinosinusitis

Journal

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY
Volume 4, Issue 12, Pages 972-979

Publisher

WILEY
DOI: 10.1002/alr.21408

Keywords

sinusitis; therapeutics; quality of life; outcome assessment; endoscopy

Funding

  1. National Institutes of Health (National Institute on Deafness and Other Communication Disorders [NIDCD]) [R01 DC005805]
  2. NIDCD [R03 DC013651-01]
  3. National Institute of Child Health and Human Development
  4. National Heart, Lung, and Blood Institute/Kaiser Permanente
  5. National Institute for Occupational Safety and Health
  6. U.S. Department of Defense

Ask authors/readers for more resources

BackgroundPrior study demonstrated that baseline 22-item Sino-Nasal Outcome Test (SNOT-22) aggregate scores accurately predict selection of surgical intervention in patients with chronic rhinosinusitis (CRS). Factor analysis of the SNOT-22 survey has identified five distinct domains that are differentially impacted by endoscopic sinus surgery (ESS). This study sought to quantify SNOT-22 domains in patient cohorts electing both surgical or medical management and postinterventional change in these domains. MethodsCRS patients were prospectively enrolled into a multi-institutional, observational cohort study. Subjects elected continued medical management or ESS. SNOT-22 domain scores at baseline were compared between treatment cohorts. Postintervention domain score changes were evaluated in subjects with at least six-month follow-up. ResultsA total of 363 subjects were enrolled with 72 (19.8%) electing continued medical management, whereas 291 (80.2%) elected ESS. Baseline SNOT-22 domain scores were comparable between treatment cohorts in sinus-specific domains (rhinologic, extranasal rhinologic, and ear/facial symptoms; p > 0.050); however, the surgical cohort reported significantly higher psychological (mean standard deviation [SD]: 16.0 +/- 8.4 vs 12.0 +/- 7.1; p < 0.001) and sleep dysfunction (13.7 +/- 6.8 vs 10.5 +/- 6.2; p < 0.001) than the medical cohort. Effect sizes for ESS varied across domains with rhinologic and extranasal rhinologic symptoms experiencing the greatest gains (1.067 and 0.997, respectively), whereas psychological and sleep dysfunction experiencing the smallest improvements (0.805 and 0.818, respectively). Patients experienced greater mean improvements after ESS in all domains compared to medical management (p < 0.001). ConclusionSubjects electing ESS report higher sleep and psychological dysfunction compared to medical management but have comparable sinus-specific symptoms. Subjects undergoing ESS experience greater gains compared to medical management across all domains; however, these gains are smallest in the psychological and sleep domains.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available